FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994846648> ?p ?o ?g. }

• W2994846648 abstract "Ascites is the accumulation of fluid within the abdominal cavity. Most women with advanced ovarian cancer and some women with advanced endometrial cancer need repeated drainage for ascites. Guidelines to advise those involved in the drainage of ascites are usually produced locally and are generally not evidence-based. Managing drains that improve the efficacy and quality of the procedure is key in making recommendations that could improve the quality of life (QoL) for women at this critical period of their lives.To evaluate the effectiveness and adverse events of different interventions for the management of malignant ascites drainage in the palliative care of women with gynaecological cancer.We searched CENTRAL, MEDLINE, and Embase to 4 November 2019. We checked clinical trial registries, grey literature, reports of conferences, citation lists of included studies, and key textbooks for potentially relevant studies.We included randomised controlled trials (RCTs) of women with malignant ascites with gynaecological cancer. If studies also included women with non-gynaecological cancer, we planned to extract data specifically for women with gynaecological cancers or request the data from trial authors. If this was not possible, we planned to include the study only if at least 50% of participants were diagnosed with gynaecological cancer.Two review authors independently selected studies, extracted data, evaluated the quality of the included studies, compared results, and assessed the certainty of the evidence using Cochrane methodology.In the original 2010 review, we identified no relevant studies. This updated review included one RCT involving 245 participants that compared abdominal paracentesis and intraperitoneal infusion of catumaxomab versus abdominal paracentesis alone. The study was at high risk of bias in almost all domains. The data were not suitable for analysis. The median time to the first deterioration of QoL ranged from 19 to 26 days in participants receiving paracentesis alone compared to 47 to 49 days among participants receiving paracentesis with catumaxomab infusion (very low-certainty evidence). Adverse events were only reported among participants receiving catumaxomab infusion. The most common severe adverse events were abdominal pain and lymphopenia (157 participants; very low-certainty evidence). There were no data on the improvement of symptoms, satisfaction of participants and caregivers, and cost-effectiveness.Currently, there is insufficient evidence to recommend the most appropriate management of drainage for malignant ascites among women with gynaecological cancer, as there was only very low-certainty evidence from one small RCT at overall high risk of bias." @default.
• W2994846648 created "2019-12-26" @default.
• W2994846648 creator A5013679579 @default.
• W2994846648 creator A5039675854 @default.
• W2994846648 creator A5042093250 @default.
• W2994846648 creator A5080073089 @default.
• W2994846648 creator A5086257507 @default.
• W2994846648 date "2019-12-11" @default.
• W2994846648 modified "2023-10-13" @default.
• W2994846648 title "Management of drainage for malignant ascites in gynaecological cancer" @default.
• W2994846648 cites W147829601 @default.
• W2994846648 cites W153659447 @default.
• W2994846648 cites W1552795667 @default.
• W2994846648 cites W1595184853 @default.
• W2994846648 cites W163267673 @default.
• W2994846648 cites W1872479823 @default.
• W2994846648 cites W1967055783 @default.
• W2994846648 cites W1968383914 @default.
• W2994846648 cites W1968413168 @default.
• W2994846648 cites W1968665353 @default.
• W2994846648 cites W1972204562 @default.
• W2994846648 cites W1973768760 @default.
• W2994846648 cites W1978503687 @default.
• W2994846648 cites W1980689809 @default.
• W2994846648 cites W1981650424 @default.
• W2994846648 cites W1983412575 @default.
• W2994846648 cites W1985973117 @default.
• W2994846648 cites W1991391990 @default.
• W2994846648 cites W1992292337 @default.
• W2994846648 cites W1995356212 @default.
• W2994846648 cites W2005664844 @default.
• W2994846648 cites W2018709904 @default.
• W2994846648 cites W2020435556 @default.
• W2994846648 cites W2024413804 @default.
• W2994846648 cites W2029604004 @default.
• W2994846648 cites W2029849095 @default.
• W2994846648 cites W2029939921 @default.
• W2994846648 cites W2034187260 @default.
• W2994846648 cites W2038167049 @default.
• W2994846648 cites W2038476799 @default.
• W2994846648 cites W2038765786 @default.
• W2994846648 cites W2045004079 @default.
• W2994846648 cites W2048843022 @default.
• W2994846648 cites W2061433365 @default.
• W2994846648 cites W2070187007 @default.
• W2994846648 cites W2075729259 @default.
• W2994846648 cites W2085204956 @default.
• W2994846648 cites W2092752027 @default.
• W2994846648 cites W2095098716 @default.
• W2994846648 cites W2095442833 @default.
• W2994846648 cites W2105062803 @default.
• W2994846648 cites W2107328434 @default.
• W2994846648 cites W2119605658 @default.
• W2994846648 cites W2120336451 @default.
• W2994846648 cites W2121080406 @default.
• W2994846648 cites W2122450633 @default.
• W2994846648 cites W2125435699 @default.
• W2994846648 cites W2134833483 @default.
• W2994846648 cites W2138550436 @default.
• W2994846648 cites W2150616104 @default.
• W2994846648 cites W2156694065 @default.
• W2994846648 cites W2171111655 @default.
• W2994846648 cites W2339694803 @default.
• W2994846648 cites W2402612453 @default.
• W2994846648 cites W2403692400 @default.
• W2994846648 cites W2409003564 @default.
• W2994846648 cites W2531269403 @default.
• W2994846648 cites W2753603515 @default.
• W2994846648 cites W2889932537 @default.
• W2994846648 cites W2947591404 @default.
• W2994846648 cites W2948841440 @default.
• W2994846648 cites W2978795816 @default.
• W2994846648 cites W81069510 @default.
• W2994846648 cites W88196633 @default.
• W2994846648 cites W2069474788 @default.
• W2994846648 doi "https://doi.org/10.1002/14651858.cd007794.pub3" @default.
• W2994846648 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6953277" @default.
• W2994846648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31825525" @default.
• W2994846648 hasPublicationYear "2019" @default.
• W2994846648 type Work @default.
• W2994846648 sameAs 2994846648 @default.
• W2994846648 citedByCount "6" @default.
• W2994846648 countsByYear W29948466482020 @default.
• W2994846648 countsByYear W29948466482021 @default.
• W2994846648 countsByYear W29948466482023 @default.
• W2994846648 crossrefType "journal-article" @default.
• W2994846648 hasAuthorship W2994846648A5013679579 @default.
• W2994846648 hasAuthorship W2994846648A5039675854 @default.
• W2994846648 hasAuthorship W2994846648A5042093250 @default.
• W2994846648 hasAuthorship W2994846648A5080073089 @default.
• W2994846648 hasAuthorship W2994846648A5086257507 @default.
• W2994846648 hasBestOaLocation W29948466482 @default.
• W2994846648 hasConcept C121608353 @default.
• W2994846648 hasConcept C126322002 @default.
• W2994846648 hasConcept C142724271 @default.
• W2994846648 hasConcept C152541439 @default.
• W2994846648 hasConcept C159110408 @default.
• W2994846648 hasConcept C168563851 @default.
• W2994846648 hasConcept C17744445 @default.
• W2994846648 hasConcept C177713679 @default.

• next